SILVERBACK THERAPEUTICS INC (SBTX)
US82835W1080 - Common Stock
| TTM (2022-9-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -85.38M | -89.48M | -32.95M | -23.97M | -17.58M | |||
| Depreciation Amortization | 720.00K | 783.00K | 640.00K | 540.00K | 480.00K | |||
| Change In Working Capital | -9.69M | 1.60M | -2.63M | 3.30M | -430.00K | |||
| Interest Paid | N/A | N/A | N/A | 40.00K | 60.00K | |||
| Other non cash items | 21.57M | 20.34M | 3.74M | 1.23M | 660.00K | |||
| OPERATING CASH FLOW | -72.78M | -66.76M | -31.20M | -18.90M | -16.88M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -1.23M | -1.37M | -920.00K | -100.00K | -450.00K | |||
| Other Investing Activity | N/A | -65.11M | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | -26.37M | -66.48M | -920.00K | -100.00K | -450.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 0.00 | -846.00K | -700.00K | 8.59M | -850.00K | |||
| Stock Issued/Repurchased | 1.61M | 1.46M | 411.81M | 20.00K | 20.25M | |||
| Other Financing Activity | N/A | 0.00 | -2.61M | N/A | N/A | |||
| FINANCING CASH FLOW | 1.61M | 614.00K | 408.51M | 8.61M | 19.40M | |||
| CHANGE IN CASH | -97.54M | -132.62M | 376.39M | -10.39M | 2.07M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -72.78M | -66.76M | -31.20M | -18.90M | -16.88M | |||
| Capital Expenditure | -1.23M | -1.37M | -920.00K | -100.00K | -450.00K | |||
| FREE CASH FLOW | -74.01M | -68.13M | -32.12M | -19.00M | -17.33M | |||
All data in USD